Preferred Label : receptors, interleukin-1;
MeSH definition : Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading
are signaling receptors, non-signaling receptors and accessory proteins required for
receptor signaling. Signaling from interleukin-1 receptors occurs via interaction
with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.;
MeSH synonym : receptors, il 1; receptors, il-1; il1 receptors; interleukin 1 receptor; il 1 receptors; receptors, il1; interleukin-1 receptors; interleukin 1 receptors; il-1 receptors; receptor, interleukin 1; receptors, interleukin 1; IL-1 Receptor; IL 1 Receptor; Receptor, IL-1; IL1 Receptor; Receptor, IL1; Interleukin-1 Receptor; Receptor, Interleukin-1;
MeSH annotation : DF: RECEPT IL 1 or RECEPT IL1;
Wikipedia link : https://en.wikipedia.org/wiki/Interleukin-1 receptor;
Is substance : O;
Origin ID : D017472;
UMLS CUI : C0063710;
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Indexing information
- AMG 108 [MeSH Supplementary Concept]
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
Semantic type(s)
Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading
are signaling receptors, non-signaling receptors and accessory proteins required for
receptor signaling. Signaling from interleukin-1 receptors occurs via interaction
with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88.
https://www.cochrane.org/fr/CD015849/CENTRALED_le-traitement-par-agonistes-des-recepteurs-du-glp-1-previent-il-les-complications-chez-les-personnes
2025
United Kingdom
review of literature
french abstract
renal insufficiency, chronic
kidney diseases
diabetes with renal manifestations
Glucagon-Like Peptide-1 Receptor
diabetic complications
glucagon-like peptide 1
chronic disease
chronic disease, nos
kidney disease, nos
receptors, interleukin-1
diabetes complications
diabetic nephropathies
persons
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1048
2021
France
COVID-19
practice guideline
Treatments
case management
interleukin-1
health planning guidelines
receptors, interleukin-6
therapeutics
interleukin-6
receptors, interleukin-1
Treatments
judgment
---